Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andrew R. Sicheneder
Genetic Alteration of a Bispecific Ligand-Directed Toxin Targeting Human CD19 and CD22 Receptors Resulting in Improved Efficacy Against Systemic B Cell Malignancy
Leukemia Research
Cancer Research
Oncology
Hematology
Related publications
Heterogeneity of Surface CD19 and CD22 Expression in B Lymphoblastic Leukemia
American Journal of Hematology
Hematology
Immunotoxins Against CD19 and CD22 Are Effective in Killing Precursor-B Acute Lymphoblastic Leukemia Cells in Vitro
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Epratuzumab Targeting of CD22 Affects Adhesion Molecule Expression and Migration of B-Cells in Systemic Lupus Erythematosus
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
CD19 and CD22 Regulate a B Lymphocyte Signal Transduction Pathway That Contributes to Autoimmunity.
Keio Journal of Medicine
Medicine
A Bispecific EpCAM/CD133-targeted Toxin Is Effective Against Carcinoma
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Ligand Directed Signaling Differences Between Rodent and Human Κ-Opioid Receptors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cd19/Cd20-Redirected Bispecific Car T Cell Treatment in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
A Sensitivity Scale for Targeting T Cells With Chimeric Antigen Receptors (CARs) and Bispecific T-Cell Engagers (BiTEs)
OncoImmunology
Oncology
Allergy
Immunology
